FDA Inspection 1068498 — Curexa - East, LLC dba Curexa
The FDA completed an inspection of Curexa - East, LLC dba Curexa on August 31, 2018 in Egg Harbor Township, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 31, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Egg Harbor Township, NJ (United States)